This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Other. Active years: 2017.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2017
Title: The Innovations of Charles R Handorf
Introduction
Charles R Handorf is a notable inventor based in Memphis, TN (US). He has made significant contributions to the field of medical diagnostics and treatment. His work focuses on understanding the immune response and microbial deposition, which has implications for diagnosing and treating systemic or autoimmune disorders.
Latest Patents
Charles R Handorf holds a patent titled "Characterization of microbial deposition and immune response at the basement membrane and methods relating thereto." This patent outlines methods for diagnosing systemic or autoimmune disorders and describes techniques for treating these conditions by inducing the production of or providing an autoantibody that recognizes a skin basement membrane component. He has 1 patent to his name.
Career Highlights
Throughout his career, Handorf has demonstrated a commitment to advancing medical science. His innovative approaches have the potential to improve patient outcomes in the realm of autoimmune diseases. His research has garnered attention for its practical applications in healthcare.
Collaborations
Charles R Handorf has worked alongside esteemed colleagues, including Patricia W Noah and Robert B Skinner, Jr. These collaborations have enriched his research and contributed to the development of his patented methods.
Conclusion
Charles R Handorf's contributions to medical innovation highlight the importance of research in diagnosing and treating complex disorders. His work continues to pave the way for advancements in the field of immunology and patient care.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile